CP, October 2017, Vol 9, No 10

Romosozumab reduces fracture risk in postmenopausal women with osteoporosis

Researchers find that the drug can be an effective treatment for women who are susceptible to fracture.…

Naturally occurring peptides show antiviral potential against common cold

Cathelicidins could be a new therapeutic strategy for the management of human rhinovirus infection, researchers suggest.…

Study lends support to genuine efficacy of antidepressants

Findings show that the antidepressants citalopram and paroxetine have significant beneficial effects, clearly outperforming placebo.…

Study finds no support for link between Alzheimer’s disease and PPIs

Researchers conclude that there is no clinically meaningful association between PPI use and risk of Alzheimer’s disease.…

Study into colon cancer highlights usefulness of pig model

The pig model can help in developing preventive strategies against gut bacterial dysbiosis and inflammation-promoted diseases, such as colon cancer, researchers find.…

Wider use of testosterone therapy is not risk free

As one of those whose passions were aroused by testosterone replacement therapy (TRT) in men, I am delighted that Clinical Pharmacist has provided Geoff Hackett with a platform to clarify the current clinical position ( Clinical Pharmacist 2017;9:195). Hackett rightly points out that we …

Promoting oral health in the community

Dental caries caused 63,000 children to be admitted to hospital for surgery in 2014. In that year, approximately one-quarter of British five-year-olds suffered with tooth decay and more than one-third of children did not see a dentist[1] ,[2] . Periodontal disease is most common in…